Joachim Kraemer

Information system, in particular for the blind

Juergen Loetzsch, Joachim Kraemer, 1998 .

Experiences in implementing uHTS--cutting edge technology meets the real world.

Christian Eggeling, Gareth Williams, Philip Gribbon, 2004, Current drug discovery technologies.

Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism.

Joachim Kraemer, Deping Wang, Dirk Winkler, 2013, Bioorganic & medicinal chemistry.

Fragment-based discovery and optimization of BACE1 inhibitors.

Joachim Kraemer, Thomas Hesterkamp, Robert Godemann, 2010, Bioorganic & medicinal chemistry letters.